ARUP Laboratories Executive and Leadership Team

Andrew Theurer, the Chief Executive Officer at ARUP Laboratories, directs the overarching strategic vision for this national reference laboratory. The Chief Executive Officer manages the complex intersection of nonprofit academic research and high-volume clinical diagnostic services. By aligning the laboratory mission with the needs of the University of Utah Department of Pathology, Theurer ensures the organization maintains a competitive edge in the health services sector. This leadership role involves overseeing long-term growth initiatives and fostering partnerships with healthcare systems across the United States. Andrew Theurer maintains rigorous standards for diagnostic accuracy and operational efficiency. Through the guidance of the Chief Executive Officer, the laboratory expands its reach, providing essential testing capabilities to diverse patient populations. Theurer drives the enterprise toward sustainable innovation, ensuring the laboratory remains a leader in the diagnostics industry while upholding the core values of the institution.

Kent Gordon, the Chief Financial Officer at ARUP Laboratories, manages the fiscal health and capital allocation strategies for this nonprofit diagnostic enterprise. The Chief Financial Officer oversees financial planning, budgeting, and revenue cycle management to ensure the laboratory sustains its academic and clinical missions. By analyzing market trends in health services, Gordon optimizes resource distribution across the organization. This leadership role requires close collaboration with the executive team to fund infrastructure investments and advanced diagnostic technology. Kent Gordon maintains strict compliance with financial regulations while driving cost-efficiency across all laboratory departments. Through the oversight of the Chief Financial Officer, the organization secures the necessary capital to support ongoing research and development. Gordon ensures the long-term financial stability of the laboratory, enabling the institution to provide high-quality diagnostic testing to healthcare providers throughout the country.

Adam Barker, the President & Chief Operations Officer, ARUP Reference Business Unit, Medical Director, Next Generation Sequencing Infectious Disease, Research & Development at ARUP Laboratories, manages the operational execution of the reference business unit. The President & Chief Operations Officer, ARUP Reference Business Unit, Medical Director, Next Generation Sequencing Infectious Disease, Research & Development directs the scaling of next-generation sequencing capabilities for infectious disease testing. By optimizing laboratory workflows, Barker ensures the efficient delivery of high-complexity diagnostic services. This leadership role involves coordinating research and development efforts to introduce innovative testing methodologies into the clinical market. Adam Barker drives operational excellence across the reference business unit, supporting the laboratory's goal of providing comprehensive diagnostic solutions. Through the guidance of the President & Chief Operations Officer, ARUP Reference Business Unit, Medical Director, Next Generation Sequencing Infectious Disease, Research & Development, the organization maintains its competitive position in the diagnostics industry while advancing the frontiers of infectious disease research.

Sarah Teofilo, the Chief Information Officer at ARUP Laboratories, architects the digital infrastructure and data security frameworks essential for high-volume diagnostic operations. The Chief Information Officer directs the integration of laboratory information systems with hospital electronic health records to streamline clinical workflows. By implementing advanced cybersecurity protocols, Teofilo protects sensitive patient data across the national network. This leadership role involves managing the technological roadmap to support rapid diagnostic turnaround times and complex data analysis. Sarah Teofilo drives digital transformation initiatives that enhance the efficiency of the laboratory's diagnostic services. Through the guidance of the Chief Information Officer, the organization leverages data analytics to improve diagnostic accuracy and operational performance. Teofilo ensures the laboratory maintains a robust technological foundation, allowing the institution to meet the evolving demands of the healthcare industry while maintaining the highest standards of data integrity.

Jonathan Genzen, the Chief Medical Officer at ARUP Laboratories, oversees the clinical quality and medical standards for the entire diagnostic testing portfolio. The Chief Medical Officer directs the development of new diagnostic assays and ensures compliance with rigorous medical accreditation requirements. By collaborating with the University of Utah Department of Pathology, Genzen bridges the gap between academic research and clinical application. This leadership role involves providing medical oversight for laboratory testing processes and consulting with healthcare providers on complex diagnostic cases. Jonathan Genzen drives initiatives to improve patient outcomes through the implementation of cutting-edge diagnostic technologies. Through the guidance of the Chief Medical Officer, the laboratory maintains its reputation for excellence in pathology and laboratory medicine. Genzen ensures that all diagnostic services meet the highest clinical standards, supporting the laboratory's mission to provide accurate and timely results to patients nationwide.